Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Maria Giulia Zampino

Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer.

scientific article published on 11 February 2009

Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period.

scientific article

First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer

scientific article published on 01 August 2007

Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy

scientific article published on 08 February 2020

K-ras status in squamous cell anal carcinoma (SCC): it's time for target-oriented treatment?

scientific article published on 2 September 2009

Lung metastases from colorectal cancer: analysis of prognostic factors in a single institution study.

scientific article published on 5 August 2014

Pre-operative radiochemotherapy with raltitrexed for resectable locally-advanced rectal cancer: a phase II study

scientific article published on 01 May 2006

Preoperative bi-fractionated accelerated radiation therapy for combined treatment of locally advanced rectal cancer in a consectutive series of unselected patients

scientific article

Primary pure gastric yolk sac tumor

scientific article published on March 31, 2010

Prognostic value of human papillomavirus in anal squamous cell carcinoma

scientific article published on 11 September 2014

Rectal cancer

scientific article published on 06 December 2008

Rectal cancer.

scientific article published in August 2004

Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer

scientific article published on 26 November 2008

The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death.

scientific article published on 2 May 2016